Publication

Sep 14, 2023

SyneurRx CEO Guochuan Emil Tsai Publishes a Research Article in《The Lancet Regional Health - Western Pacific》, Indicating Sharp Increase in Suicide Attempts During the Three Years of COVID-19 Pandemic in French Polynesia

July 13, 2022

SyneuRx Publishes a Research Paper in《Journal of Alzheimer's Disease Reports》and Presents Disease-modifying Medication Results of Lithium Benzoate, Demonstrated as a Safe and Effective Drug Candidate for Alzheimer's Disease or other Neurodegenerative Disorders. (Accepted)

May 16, 2022

SyneuRx Publishes Pan-coronal Antiviral Therapeutic Research Results of Pentarlandir®, demonstrated as a Safe and Effective Drug Candidate, in 《ACS Pharmacology & Translation Science》